July 23, 2016
Recommended Topic Related To:

Levulan Kerastick

"Rebound growth of infantile hemangiomas (IHs) may occur in up to a quarter of patients treated with oral propranolol (OP) therapy, and early discontinuation of therapy may double this risk, according to a new retrospective study. These findings a"...

A A A

Levulan Kerastick




Overdosage
Contraindications

OVERDOSE

LEVULAN KERASTICK (aminolevulinic acid) Topical Solution Overdose: LEVULAN KERASTICK (aminolevulinic acid) Topical Solution overdose have not been reported. In the unlikely event that the drug is ingested, monitoring and supportive care are recommended. The patient should be advised to avoid incidental exposure to intense light sources for at least 40 hours. The consequences of exceeding the recommended topical dosage are unknown.

BLU-U Light Overdose: There is no information on overdose of blue light from the BLU-U Blue Light Photodynamic Therapy Illuminator following LEVULAN KERASTICK Topical Solution application.

CONTRAINDICATIONS

The LEVULAN KERASTICK (aminolevulinic acid) for Topical Solution plus blue light illumination using the BLU-U Blue Light Photodynamic Therapy Illuminator is contraindicated in patients with cutaneous photosensitivity at wavelengths of 400-450 nm, porphyria or known allergies to porphyrins, and in patients with known sensitivity to any of the components of the LEVULAN KERASTICK (aminolevulinic acid) for Topical Solution.

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 10/8/2008

Overdosage
Contraindications

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.